Inappropriate ADH syndrome
MONDO:0006802A syndrome characterized by abnormal secretion of antidiuretic hormone in conjunction with neoplastic growth occurring anywhere in the body.
Also known as: SIADH, ectopic ADH secretion, ectopic antidiuretic hormone secretion, inappropriate ADH secretion, inappropriate Arginine vasopressin secretion, inappropriate antidiuretic hormone secretion syndrome, syndrome of inappropriate antidiuretic hormone, syndrome of inappropriate antidiuretic hormone secretion
9 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Japanese study monitors safety of samsca for SIADH patients
Disease control OngoingThis study tracks the safety of the drug Samsca (tolvaptan) in 300 Japanese patients with low sodium levels caused by SIADH. Researchers will record any side effects or special situations that occur during routine use. The goal is to confirm the drug's safety in real-world settin…
Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Pituitary patients followed for years to uncover key outcomes
Knowledge-focused OngoingThis study follows 1500 patients with pituitary gland disorders to see how they fare over time, whether treated with medication, surgery, or just monitoring. Researchers will track tumor regrowth after surgery to find clues that predict recurrence. The goal is to learn, not to te…
Sponsor: University of Alberta • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC